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Synergistic Impairment of Glucose Homeostasis in ob/ob
Mice Lacking Functional Serotonin 2C Receptors
Jennifer M. Wade, Punita Juneja, Adrienne W. MacKay, James Graham, Peter J. Havel,
Laurence H. Tecott, and Evan H. Goulding
Department of Psychiatry (J.M.W., P.J., A.W.M., L.H.T., E.H.G.), University of California, San Francisco, San Francisco,
California 94158; and Department of Nutrition (J.G., P.J.H.), University of California, Davis, Davis, California 95616
To investigate how serotonin and leptin interact in the reg-
ulation of energy balance and glucose homeostasis, we gen-
erated a genetic mouse model, the OB2C mouse, which lacks
functional serotonin 2C receptors and the adipocyte hormone
leptin. The OB2C mice exhibited a dramatic diabetes pheno-
type, evidenced by a synergistic increase in serum glucose
levels and water intake. The severity of the animals’ diabetes
phenotype would not have been predicted from the pheno-
typic characterization ofmice bearingmutations of either the
leptin (OBmutantmice) or the serotonin 2C receptor gene (2C
mutant mice). The synergistic impairment in glucose ho-
meostasis developed at an age when OB2Cmice did not differ
in bodyweight fromOBmice, suggesting that this impairment
was not an indirect consequence of increased adiposity. We
also demonstrated that the improvement in glucose tolerance
in wild-type mice treated with the serotonin releaser and re-
uptake inhibitor fenfluraminewasblunted in 2Cmutantmice.
Thesepharmacological andgenetic findings provide evidence
that the serotonin 2C receptor has direct effects on glucose
homeostasis. (Endocrinology 149: 955–961, 2008)
SUSCEPTIBILITY TO OBESITY and type 2 diabetes isknown to be associated with a polygenic mode of
inheritance (1). This is in accord with a complex set of
interactions among the multiple pathways through which
energy balance and glucose homeostasis are regulated.
Insights into the pathophysiology of these disorders
would therefore be facilitated by an understanding of the
manner in which such pathways interact. For example,
serotonin- and leptin-responsive pathways have both been
implicated in the regulation of energy balance and glucose
homeostasis, yet the extent to which they interact has been
unclear.
Central serotonin [5-hydroxytryptamine (5-HT)] systems
have long been implicated in the regulation of food intake
and energy balance, as highlighted by the clinical use of the
serotonin releaser and reuptake inhibitor fenfluramine as an
appetite suppressant and weight loss medication (2). More
recently a growing concern regarding the diabetogenic side
effects of the atypical antipsychotics, which have nonspecific
5-HT receptor antagonist properties, has highlighted the
need for an improved understanding of serotonin’s influence
on glucose homeostasis (3). A role for serotonin in glucose
homeostasis is also consistent with prior studies indicating
that fenfluramine improves glucose tolerance and insulin
action (4).
The serotonin 2C receptor (5HT2CR), one of at least 14 dis-
tinct subtypes of 5-HT receptors, has been shown to play an
important role in serotonergic effects on energy balance. Ex-
pression of 5HT2CR is restricted to the central nervous system,
in which it is found in both hypothalamic and extrahypotha-
lamic regions implicated in energy balance and glucose regu-
lation (5, 6).Micewith targeted null mutations of the htr2c gene
(2C mutant mice) are resistant to the anorectic effects of fen-
fluramine (7). In addition, 2Cmutantmice are hyperphagic and
developmild obesity, hyperinsulinemia, and impaired glucose
tolerance by the age of 6 months (8). These deficits are
accelerated and exaggerated in 2C mutant mice fed a high-fat
diet, consistent with the possibility that their hyperinsulinemia
and glucose intolerance results indirectly as a consequence of
their elevated adiposity (8).
Several lines of evidence support the possibility that se-
rotonin and leptin may regulate energy balance and glucose
homeostasis by influencing common neural pathways. Both
leptin receptors and 5HT2CRs are found within multiple
hypothalamic structures implicated in energy balance. These
include the ventromedial, dorsomedial, paraventricular, lat-
eral, and arcuate hypothalamic nuclei (5, 6, 9, 10). Notably,
leptin receptors expressed in the arcuate nucleus have been
shown to play an important role in glucoregulation (11).
5HT2CRs are also expressed in this region, providing a po-
tential site at which leptin and serotonin systems could in-
teract to regulate glucose homeostasis.
To investigate potential interactions between 5HT2CR-
and leptin-responsive pathways on the regulation of energy
balance and glucose homeostasis, we crossed mice with null
mutations of the htr2c gene with animals bearing null mu-
tations of the leptin (lep) gene to generate mice deficient in
both genes (OB2C double mutant mice). Phenotypic analysis
of these animals and the effects of fenfluramine in wild-type
and 2C mutant mice led us to report here that 5HT2CRs
mediate central serotonergic influences on peripheral glu-
cose homeostasis in a manner that is influenced by leptin
signaling.
First Published Online November 26, 2007
Abbreviations: 5-HT, 5-Hydroxytryptamine; 5HT2CR, serotonin 2C
receptor; wild-type experimental mice.
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Materials and Methods
Animals
Male mice heterozygous for the obese spontaneous mutation (Lepob)
were obtained from the Jackson Laboratory (B6.V-Lepob/J; Bar Harbor,
ME) and bred with female mice heterozygous for a null mutation of the
X-linked htr2c gene (12). Both mutations were congenic on a C57BL/6J
background. From this cross, female mice heterozygous for both the
Lepob and htr2c mutations (htr2c/htr2c, Lepob/Lep) and male mice
heterozygous for the lep mutation (Lepob/Lep) were then bred to pro-
duce the male experimental mice (WT: htr2c/Y, Lep/Lep; 2C:
htr2c/Y, Lep/Lep; OB: htr2c/Y, Lepob/Lepob; OB2C: htr2c/Y, Lepob/
Lepob) and heterozygous mice for additional breeding. For pharmaco-
logical studies, experimental mice were generated by breeding female
mice heterozygous for the htr2c mutation with male C57BL6/J mice
obtained from the Jackson Laboratory. Genotyping for the htr2c mu-
tation was performed by PCR analysis using a primer within the neo-
mycin resistance gene (NeoD: 5-CACCTTGCTCCTGCCGAGAAA-3)
and flanking primers within the htr2c gene (2C forward: 5-GCTCA-
GAATTCTGGAAATGTGT-3; 2C reverse: 5-CGGACTGCTAAATT-
GGGTC-3) to produce a 114-bp band for WT mice and a 600-bp band
for 2C mutant mice. Genotyping for the obese mutation was performed
as previously described (13). All animals were housed at 20–24 C on a
12-h light, 12-h dark cycle (lights on at 0700 h) with free access to water
and a standard chow diet (PicoLab Mouse Diet 20 5150; Purina Mills,
Richmond, IN) except where indicated. Experiments were performed in
accordance with the guidelines of the National Institutes of Health
Guide for Care and Use of Laboratory Animals and the University of
California, San Francisco, InstitutionalAnimal Care andUseCommittee.
Food and water intake measurements
Mice were individually housed for 16 d in cages with feeders and
water bottles mounted at one end. Animals were weighed before place-
ment in the monitoring apparatuses and again at the end of data col-
lection period. Intake of food and water were determined daily. Mean
intake for the last 12 d of data collectionwas used for group comparisons
to allow 4 d of acclimation to the housing conditions. The mice were run
in 12 cohorts of three to 21 mice determined by the intermittent gen-
eration of mice from the breeding colony. The mice ranged in age from
2 to 8 months (2 months: WT, n 10, 2C, n 10, OB, n 15, OB2C, n
10; 3 months: WT, n  4, 2C, n  2, OB, n  6, OB2C, n  4; 4 months:
WT, n  7, 2C, n  10, OB, n  10, OB2C, n  7; 5 months: WT, n 
3, 2C, n  5, OB, n  6, OB2C, n  3; 6 months: WT, n  3, 2C, n  3,
OB, n 1, OB2C, n 2; 7months:WT, n 2, 2C, n 5, OB, n 4; OB2C,
n  4; 8 months: WT, n  4, 2C, n  6, OB, n  7; OB2C, n  4), and
where possible, individual mice were tested at multiple ages (one run:
n  47 mice; two runs: n  29; three runs: n  12; four runs: n  4) to
assess changes in intake with age.
Urine glucose
Mice were removed between 1300 and 1700 h from group housing in
which food and water were available ad libitum and singly housed in a
clean cagewithout bedding, food, orwater. Urine producedwas applied
to a urinalysis reagent strip (Diastix; Bayer, Elkhart, IN) and scored on
a color scale for glucose (0, 100, 250, 500, 1000, 2000 mg/dl). Mice were
tested between 2 and 8 months of age (2 months: WT, n 6, 2C, n 14,
OB, n  13, OB2C, n  11; 3 months: WT, n  8, 2C, n  9, OB, n  6,
OB2C, n  7; 4 months: WT, n  1, 2C, n  6, OB, n  6, OB2C, n 
7; 5 months: WT, n  8, 2C, n  8, OB, n  12, OB2C, n  10; 6 months:
WT, n  5, 2C, n  8, OB, n  8, OB2C, n  6; 7 months: WT, n  4,
2C, n  1, OB, n  5, OB2C, n  4; 8 months: WT, n  6, 2C, n  4, OB,
n  2, OB2C, n  8).
Fasting serum physiology
Mice were weighed and individually housed for 16 h before an 8-h
fast beginning at 0700 h. Mice were then rapidly decapitated for col-
lection of trunk blood. Samples were centrifuged to collect serum for
measurement of glucose, insulin, glucagon, and corticosterone. Mice
were tested from 2 to 10 months of age (2 months: WT, n  7, 2C, n 
8, OB, n  10, OB2C, n  11; 4 months: WT, n  6, 2C, n  8, OB, n 
11, OB2C, n  8; 6 months: WT, n  6, 2C, n  10, OB, n  12, OB2C,
n  9; 10 months: WT, n  11, 2C, n  10, OB, n  15, OB2C, n  7).
Glucose was measured using a GM7 Analox instrument (Analox In-
struments Ltd., Lunenberg, MA) using the glucose oxidase method.
Insulin was measured using the ALPCO ultrasensitive mouse insulin
enzyme immunoassay no. 10-1150-01 (ALPCODiagnostics, Salem, NH).
Glucagon and corticosterone were measured by RIA using the Linco
glucagon RIA kit GL-32K (Linco Research, St. Charles, MO), and a rat
andmouse corticosteroneRIAkit (no. 07-120103;MPBiomedicals, Solon,
OH).
Weaning blood glucose
Mice were removed from their cages at 3 wk of age, and a drop of tail
blood was applied to a One Touch Ultra glucometer (LifeScan Johnson
& Johnson, Milpitas, CA) to measure blood glucose levels (WT: n  8;
2C: n  16; OB: n  18; OB2C: n  13).
Glucose tolerance tests
Beginning at 0700 h, mice were fasted for 8 h before blood collection
from the tail vein for determination of baseline glucose levels (2 g/kg
dose: WT, n  15, 2C, n  12, OB, n  14, OB2C, n  15; 0.2 g/kg dose:
WT, n 5, 2C, n 5, OB, n 7, OB2C, n 10). Mice were then weighed
and administered an ip injection of d-glucose (Sigma, St. Louis, MO) in
distilled water. Subsequently blood was collected from the tail vein and
centrifuged for serum collection at multiple time points for up to 2 h. For
glucose tolerance tests with fenfluramine, 6 mg/kg fenfluramine or
vehicle was administered ip immediately after baseline blood collection
and before 2 g/kg glucose injection (WT, n 8; 2C, n 8). Fenfluramine,
vehicle, and glucose were all injected at a volume of 10 l/g of body
weight. Fenfluramine was obtained from Sigma and was dissolved in
0.9% NaCl. Serum glucose was measured using a Trinder glucose ox-
idase kit (Mega Diagnostics, Los Angeles, CA).
Insulin tolerance tests
Insulin tolerance tests were carried out only on OB and OB2C mice
because the dose of insulin required to lower serumglucose in thesemice
would be lethal to nondiabetic mice. Beginning at 0700 h, mice were
fasted for 8 h before blood collection from the tail vein for determination
of baseline glucose levels (OB, n  9; OB2C, n  5). Mice were then
weighed and administered an ip injection of 12 U/kg human insulin
(Sigma) in distilledwater. Subsequently bloodwas collected from the tail
vein and centrifuged for serum collection at multiple time points for up
to 2 h.
Pancreatic histology
Mice (OB, n  5; OB2C, n  6) were anesthetized with avertin
(2–2-2-tribromoethanol) and perfused with 0.9% NaCl followed by 4%
paraformaldehyde. Histological analysis, quantification of tissue area,
and counting of cells were performed as described previously (14).
Immunohistochemical and immunofluorescence analyses were per-
formed on paraffin sections as described previously (15). The following
primary antibodies were used: guinea pig antiinsulin diluted 1:500
(Linco Research), rabbit antiglucagon diluted 1:500 (Linco Research).
The following secondary antibodieswere used for immunofluorescence:
fluorescein isothiocyanate-conjugated anti-guinea pig (Invitrogen,
Carlsbad, CA); Cy3-conjugated antirabbit diluted 1:500 (Invitrogen).
Glucagon- and insulin-positive cells were quantitated using OpenLab
software (Improvision, Lexington, MA).
Glucose-stimulated insulin release
Eleven-week-old mice (OB, n  5; OB2C, n  7) were euthanized by
cervical dislocation, and pancreases were immediately inflated by in-
jection of 3 ml of collagenase into the bile duct. The pancreases were
removed and digested in collagenase at 37 C for 13–17 min followed by
straining, centrifugation, andwashing. Islets were then isolated by Ficoll
gradient centrifugation, and six medium-sized islets were picked into
5-ml, round-bottom tubes containing RPMI 1640 media with 0.1% BSA.
Between three and six tubes of islets were used for each animal at each
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concentration. Stock glucose was added to each tube to achieve con-
centrations of 75, 150, 300, and 600 mg/dl. Samples were then incubated
with shaking for 1 h at 37 C followed by brief centrifugation and removal
of supernatant for measurement of insulin by RIA using the Linco rat
insulin RIA kit no. RI13K (Linco Research).
Statistics
Analyses of body weight, chow, and water intake were performed
using a mixed-linear model (mixed procedure; SAS Institute Inc., Cary,
NC) with mouse, htr2, and lep genotypes, and age in months defined as
class variables and age as a repeated measure. The analysis of urine
glucose levels was also carried out using a mixed-linear model with
mouse, htr2c and lep genotypes, age in months, and urine glucose de-
fined as class variables and age as a repeated measure. ANOVA was
used for comparing fasting serum values (SPSS, Chicago IL). The anal-
yses of the glucose tolerance tests, insulin tolerance tests, and glucose-
stimulated insulin release used repeated-measures ANOVA (SPSS). In
the case of the glucose tolerance tests with fenfluramine, each mouse
received vehicle and drug treatment in a crossover design, with a 1-wk
interval between tests, and the difference between the glucose levels for
drug treatment and vehicle treatment at each time point was analyzed
by repeated-measures ANOVA (SPSS).
Results
Regulation of food and water intake
To determine how mutations in the htr2c and lep genes
interact in the regulation of ingestion, daily food and water
intake were measured in WT, 2C mutant, OB mutant, and
OB2Cdouble-mutantmice ranging in age from2 to 8months.
These measurements revealed significant effects of age and
the htr2c and Lepobmutations on both food andwater intake
(Fig. 1, A and B). In addition, a significant synergistic inter-
action of the two mutations with age was observed for both
food and water intake. OB2C double-mutant mice exhibited
a large nonadditive increase in intake that declined slowly
with age, compared with the WT and single-mutant mice
(Fig. 1, A and B). This increase was greater than predicted
based on the phenotypes of the single mutant lines and was
particularly striking for water intake. For water intake, there
was both a significant interaction of the two mutations with
age and an interaction of the two genes across all ages. Thus,
despite the decline in water intake to similar levels for all
groups by 5 months of age, a significant interaction between
the two genes across all ages is still detected [average water
intake all mice from 2 to 8 months (mean  se): WT, 4.3 
0.1; 2C, 4.2  0.1; OB, 4.9  0.3; OB2C, 8.0  0.8]. A similar
synergistic interaction was not observed for body weight.
Although significant effects of age and htr2c and lep genotype
on body weight were observed, OB2Cmutant mice were not
heavier than expected based on the phenotypes of the single
mutants alone (Fig. 1C).
Glucose homeostasis
Glucose levels were determined in the urine of WT, 2C,
OB, and OB2C mice from 2 to 8 months of age. A significant
effect of age and the Lepob mutation was observed on urine
glucose levels. In addition, there was a significant interaction
between the htr2c and Lepobmutations, with the OB2C dou-
ble mutants exhibiting elevated urine glucose levels not pre-
dicted by a simple additive effect of the single gene muta-
tions (Fig. 2). This interaction indicates that the combined
effect of the two mutations produced a synergistic impair-
ment in glucose homeostasis.
To confirm the presence of a synergistic impairment in the
OB2C double mutants, fasting serum physiological param-
eters inWT, 2C,OB, andOB2Cmicewere investigated. There
were significant effects of age and htr2c and lep genotype on
fasting serum glucose levels. Again, a significant interaction
between the two mutations on glucose levels was observed,
with the OB2C mutants exhibiting a nonadditive increase in
glucose levels relative to theWTand single-mutantmice (Fig.
3A).
The elevated fasting glucose levels of the OB and OB2C
mutant mice declined with age at a similar rate, and by 10
months no differences in glucose levelswere detected among
the groups (Fig. 3A). The improvement in fasting glucose
with age in OB mice is consistent with previous work, in-
dicating that the diabetes phenotype of OB mice on a
C57BL/6 background normalizes with age (16). To investi-
gate when the diabetes phenotype in these mice develops,
blood glucose levels were determined at weaningwhenmice
were 3 wk old. At this age, there were no significant effects
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FIG. 1. Chow and water intake and body weight in WT (circles, solid
line), 2C (triangles, dashed line), OB (squares, solid line), and OB2C
(diamonds, dashed line) mice. A, Average daily chow intake. There
was a significant effect of both htr2c and lep genotypes and a syner-
gistic interaction of the two with age (htr2c, P  0.0001; lep, P 
0.0001; age, P  0.0001; htr2c  lep, P  0.8; htr2c  age, P  0.5;
lep age, P 0.0001; htr2c lep age, P 0.004). B, Average daily
water intake. There was a significant effect of both htr2c and lep
genotypes and a synergistic interaction of the two (htr2c, P 0.0001;
lep, P 0.0001; age, P 0.0001; htr2c lep, P 0.0001; htr2c age,
P  0.0006; lep  age, P  0.0001; htr2c  lep  age, P  0.0001).
C, Body weight (BW). There was a significant effect of both htr2c and
lep genotypes without a significant interaction of the two (htr2c, P 
0.007; lep, P  0.0001; age, P  0.0001; htr2c  lep, P  0.8; htr2c 
age, P  0.1; lep  age, P  0.0001; htr2c  lep  age, P  0.8).
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of the htr2c or lep genotypes on blood glucose levels [blood
glucose, milligrams per deciliter (mean se): WT, 151 16;
2C, 169  12; OB, 186  11; OB2C, 182  13; ANOVA: htr2c,
P 0.6, lep, P 0.07, htr2c lep P 0.4]. This indicates that
the diabetes phenotype develops after weaning, between the
ages of 3 and 8 wk.
In contrast with the alterations in glucose levels, insulin
levels were significantly altered only by the Lepob mutation
(Fig. 3B). Glucagon and corticosteronewere alsomeasured at
2 months of age, when the difference in glucose levels be-
tween OB and OB2C mutants was largest. At this age, only
the Lepob mutation resulted in significant elevations of insu-
lin, glucagon, and corticosterone (Table 1). In contrast, there
were significant effects of both htr2c and Lepobmutations as
well as a significant interaction between the mutations on
glucose levels at this age.
A glucose tolerance test performed on WT, 2C, OB, and
OB2C mice with 2 g/kg glucose also revealed a significant
nonadditive effect of the combined mutations on glucose
levels (Fig. 4A). Glucose levels in both the OB and OB2C
mutant mice returned to baseline values more slowly in
comparisonwith theWT and 2Cmutant mice, as revealed by
the significant interaction of the Lepob mutation with time. In
contrast, a three-way interaction between time and the two
gene mutations was not significant, indicating that the sig-
nificant interaction of the two mutations was attributable to
the altered baseline glucose levels (Fig. 4A). Similar effects
were seen with a lower glucose dose of 0.2 g/kg (supple-
mental Fig. 1, published as supplemental data on The En-
docrine Society’s Journals Online Web site at http://
endo.endojournals.org). An insulin tolerance test performed
on OB and OB2Cmice showed significant effects of time and
htr2cmutation and a significant interaction of the two (Fig.
4B), indicating that OB2C mice had altered sensitivity to an
insulin challenge, compared with OB mice.
Pancreatic islet morphology and function
To determine whether the OB2C double-mutant pheno-
type was associated with alterations of pancreatic morphol-
ogy, pancreatic tissue from OB and OB2C double mutants
was examined at 11 wk of age, when phenotypic differences
in glucose levels were largest. No significant difference in
islet number or total islet area was observed (number,
mean  se: OB, 18.6  3, OB2C, 15.6  1.9, P  0.5; nor-
malized area, mean  se: OB, 1  0.3, OB2C, 0.6  0.04, P 
0.2), nor were there differences in the ratios of insulin-pos-
itive to glucagon-positive cells (insulin/glucagon, mean 
se: OB, 2.3  0.4, OB2C, 2.0  0.4, P  0.60). To determine
whether the islets of OB and OB2C mutant mice differed in
their ability to release insulin, a glucose-stimulated insulin
release study was also performed. Consistent with the lack
of difference in pancreatic morphology, there was no signif-
icant difference in glucose-stimulated islet insulin produc-
tion between the two groups (Fig. 5).
Glucose tolerance test with fenfluramine
The synergistic impairment of glucose homeostasis in
OB2C mutants may be attributable to an indirect effect of
increased adiposity or the result of a previously underap-
preciated role for 5HT2CRs in glucose homeostasis. How-
ever, no significant differences in the weights of adipose
depots were observed between OB and OB2C mutants at 2
months of age (t tests, mean  se, values in grams: epidid-
ymal OB, 3.8  0.8, OB2C, 3.9  1.2, P  0.8; perirenal OB,
1.1  0.5, OB2C, 1.4  0.3, P  0.1; omental OB, 1.1  0.2,
OB2C, 1.2  0.2, P  0.2; femoral OB, 1.5  0.3, OB2C, 1.7 
0.3, P  0.2) despite large differences in glucose levels. This
suggests that 5HT2CRs may have a role in glucoregulation
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FIG. 3. Fasting serum glucose and insulin over time in WT (circles,
solid line), 2C (triangles, dashed line), OB (squares, solid line), and
OB2C (diamonds, dashed line) mice. A, Serum glucose. There was a
significant effect of both htr2c and lep genotypes and a synergistic
interaction of the two (htr2c, P  0.001; lep, P  0.0001; age, P 
0.0001; htr2c  lep, P  0.007; htr2c  age, P  0.5; lep  age, P 
0.0001; htr2c  lep  age, P  0.1). B, Serum insulin. There was a
significant effect only of the lep genotype (htr2c, P  0.5; lep, P 
0.0001; age, P 0.7; htr2c lep, P 0.3; htr2c age, P 0.99; lep
age, P  0.6; htr2c  lep  age, P  0.99).
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FIG. 2. Urine glucose inWT (circles, solid line), 2C (triangles, dashed
line), OB (squares, solid line), and OB2C (diamonds, dashed line)
mice. There was a significant effect of lep genotype and an interaction
of lep and htr2c genotypes (htr2c, P 0.051; lep, P 0.0001; age, P
0.0001; htr2c  lep, P  0.04; htr2c  age, P  0.99; lep  age, P 
0.0001; htr2c  lep  age, P  0.99).
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that is independent of phenotypic differences in adiposity.
To further evaluate this hypothesis, we examined the effect
of fenfluramine on glucose tolerance in young WT and 2C
mutant mice at an age before the development of phenotypic
differences in adiposity. 2C mutant mice and their WT lit-
termates were injected with either vehicle or 6 mg/kg fen-
fluramine and then administered a glucose tolerance test.
Fenfluramine treatment produced a more rapid decline to-
ward baseline glucose levels in WT mice, compared with 2C
mutant mice, as revealed by the significant interaction of the
htr2cmutation with time (Fig. 6). This differential response
of the WT and 2C mutant mice to fenfluramine occurred at
an age when the mice were not diverged in body weight (t
test, mean  se, values in grams: WT, 22.0  0.7, 2C, 23.6 
0.6, P  0.09), indicating that the 5HT2CR has a role in
regulation of glucose homeostasis that is independent of its
role in the regulation of food intake and body weight.
Discussion
We report that combined mutations of the lep and htr2c
genes results in a synergistic impairment of glucose ho-
meostasis, accompanied by a synergistic increase in water
intake in OB2C mice, indicating that leptin and the 5HT2CR
interact in glucoregulation. The differences in glucose levels
and food and water intake seen between OB and OB2C mice
were not attributable to phenotypic differences in adiposity,
suggesting a body weight-independent role of the 5HT2CR
in regulation of glucose homeostasis. In this study, the ele-
vation of body weight in 2C mutant mice, although signif-
icant, is somewhat less than reported earlier (8). Factors in the
present study that may account for this include the exposure
of animals to periods of individual housing and potential
maternal effects of heterozygosity for the Lepob mutation in
dams from which experimental animals were derived.
Several prior functional and neuroanatomical studies
raised the possibility that interactions between leptin- and
serotonin-responsive neuronal pathways could exist. OB
mice were reported to have decreased expression of seroto-
nin transporter mRNA in the dorsal raphe´ (17), and leptin
treatment of OB mice increased the concentration of seroto-
nin in hypothalamic and brain stem structures (18). In an-
other study, a mouse line modeling leptin resistance (in-
duced by constitutive leptin overexpression) was crossed
with 2C mutant mice, resulting in enhanced sensitivity to
high-fat diet-induced obesity and hyperinsulinemia (19). No-
tably, both the 5HT2CR and leptin receptors are expressed in
hypothalamic regions implicated in energy balance and glu-
cose homeostasis, including the arcuate nucleus of the hy-
pothalamus, the dorsomedial hypothalamus, the paraven-
tricular hypothalamus, and the lateral hypothalamus (5, 6, 9,
10). Coexpression of 5HT2CRs and leptin receptors has also
been shown to occur at the cellular level: leptin receptors are
expressed on serotonergic neurons in the raphe´ nuclei (15, 20,0 30 60 90 120
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FIG. 4. A, Glucose tolerance test with 2 g/kg glucose in 2-month-old
WT (circles, solid line), 2C (filled triangles, dashed line), OB (squares,
solid line), and OB2C (filled diamonds, dashed line) mice. There was
a significant effect of both htr2c and lep genotypes and a significant
interaction between the two (htr2c, P  0.008; lep, P  0.0001; time,
P  0.0001; htr2c  lep, P  0.03; htr2c  time, P  0.7; lep  time,
P 0.0001; htr2c lep time,P 0.9). B, Insulin tolerance test with
12 U/kg in 10-wk-old OB (squares, solid line) and OB2C (filled dia-
monds, dashed line) mice. There was a significant effect of htr2c (P
0.008), time (P 0.0001), and a significant interaction of htr2c time
(P  0.03).
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FIG. 5. Glucose-stimulated insulin release from isolated pancreatic
islets of 2-month-old OB (squares, solid line) and OB2C (diamonds,
dashed line) mice. There was a significant effect of glucose but not
htr2c genotype (htr2c, P  0.3; glucose, P  0.0001; htr2c  glucose,
P  0.9).
TABLE 1. Fasting serum physiological parameters at 2 months of age
Measurement WT 2C OB OB2C 2c, P value lep P value 2c  lep, P value
Glucose, mg/dl 191  31 183  29 364  26 496  25 0.03 0.0001 0.02
Insulin, ng/ml 0.7  5 0.6  5 26  4 20  4 0.6 0.0001 0.6
Glucagon, pg/ml 35  23 38  16 136  16 91  13 0.3 0.0001 0.2
Cort, ng/ml 77  25 68  24 248  21 301  20 0.3 0.0001 0.2
Measurements reported are the mean and SEM. Significance values are from 1  2 ANOVA for each measurement.
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21), and these serotonergic neurons have been shown to
accumulate leptin (22). 5HT2CRs are also expressed on lep-
tin-sensitive proopiomelanocortin neurons in the arcuate nu-
cleus (23), a brain region through which leptin regulates
glucose homeostasis (11). The 5HT2CR does not appear to be
expressed outside the central nervous system, and quanti-
tative RT-PCR on mouse pancreas tissue did not reveal any
expression of 5HT2CR mRNA, both in our hands (data not
shown) and elsewhere (24).
At 2 months of age, OB2C double-mutant mice had dra-
matically increased food (124% of OB intake) and water
(198% of OB intake) intake, compared with their OB litter-
mates. In addition, OB2C double mutants exhibited elevated
urine glucose levels as well as higher fasting glucose and
impaired glucose tolerance, demonstrating a synergistic in-
teraction of the lep and htr2c genes in the regulation of glu-
cose homeostasis.
The impaired glucose homeostasis phenotype of both OB
andOB2Cmice ameliorates as themice age. This finding had
previously been observed in OB mice on the C57BL/6 back-
ground (16); however, the mechanisms underlying this age-
dependent effect have not been fully delineated. Interest-
ingly, serum insulin concentrations do not appear to change
significantly with age (Fig. 3B), raising the possibility that
euglycemia seen in older OBmicemay result from improved
insulin sensitivity, rather than increased insulin production.
In parallel with the improvement of glucose levels with age,
both OB and OB2C mice exhibit a normalization of food and
water intake. Given the well-established effects of elevated
blood glucose on osmotic regulation, it is likely that the
normalization of water intake is secondary to normalization
of serum glucose levels. Because hyperphagia is also linked
to diabetes mellitus (25–27), the normalization of feeding in
these mice may also occur secondary to their improvement
in glucose homeostasis. Despite the marked hyperphagia of
young adult OB2C mice, their body weights did not differ
from those of OBmice. This is consistent with the notion that
attempts to compensate for energetic losses from urinary
glucose excretion contribute to hyperphagia in mice of both
genotypes (25).
To better examine the synergistic interaction between the
lep and htr2c genes, we focused attention on 2-month-old
mice, the age at which their diabetes is maximal. We did not
see any differences between 2-month-old OB andOB2Cmice
in pancreas morphology or the ability of islets to respond in
vitro to glucose (Fig. 5), suggesting that the double mutant
phenotype is unlikely attributable to a defect in pancreatic
development or intrinsic islet cell function. However, this
does not exclude the possibility that central regulation of
pancreatic function may differ in OB and OB2C mice, i.e.
through effects of central serotonin on the sympathetic and
parasympathetic nervous systems (28).
It is also possible that phenotypic influences on insulin
sensitivity contribute to the exacerbation of diabetes in OB2C
mice. Consistent with this possibility, an insulin tolerance
test indicated altered sensitivity to injected insulin in OB2C
mice, compared with OB mice. However, interpretation of
these insulin tolerance test results is confounded by the sig-
nificantly elevated (relative to OB) fasting glucose levels of
OB2C mice. It is noteworthy, however, that despite the
higher fasting serum glucose levels of the double mutants,
the fasting serum insulin levels of two groups do not differ.
This is consistent with the possibility that reduced insulin
sensitivity contributes to the enhanced disruption of glucose
homeostasis in OB2C mice.
Whereas a null mutation of the htr2c gene does not result
in impairment of glucose homeostasis in young, lean mice,
Nonogaki et al. (8) showed that obese 2C mutant mice do
develop impaired glucose homeostasis. However, it was un-
clear whether this reflected a direct impairment by the htr2c
mutation or an indirect consequence of enhanced adiposity,
which is in and of itself a major risk factor for type 2 diabetes
(29). Our observation that the effects of fenfluramine on
glucose tolerance are blunted in 2C mutant mice indicates
that manipulation of the 5HT2CR can play a role in glucose
regulation in the absence of obesity. This suggests that
young, lean 2C mutant mice, which have normal glucose
tolerance, are somehow able to compensate for their chronic
lack of 5HT2CR. This compensation appears to fail in diet-
induced obesity [a condition accompanied by leptin resis-
tance (8)], in a genetic model of leptin resistance (19), and in
the absence of leptin (this study). These data suggest that the
manner in which 2C mutant mice maintain glucose ho-
meostasis is leptin dependent and that impairment of the
leptin system augments the impact of 5HT2CR signaling on
glucose homeostasis.
In summary, our findings indicate that serotonin and lep-
tin interact synergistically to regulate glucose homeostasis.
These findings may have significant clinical implications be-
cause diabetes and obesity associated with atypical antipsy-
chotic drug treatment pose substantial obstacles in the treat-
ment of schizophrenia and bipolar disorder (4). Atypical
antipsychotic drugs are high-affinity antagonists of the
5HT2CR (30), and 5HT2CR occupancy has been found to
correlate with the obesigenic and diabetogenic effects of
these drugs (31). Furthermore, our finding that the 5HT2CR
interacts with the leptin system to regulate glucose ho-
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FIG. 6. Glucose tolerance test with 2 g/kg glucose with 6 mg/kg D-
fenfluramine or vehicle in 3-month-old WT and 2C mice. Shown on
graph are WT with vehicle (circles, solid line), WT with D-fenflura-
mine (squares, solid line), 2Cwith vehicle (triangles, dashed line), and
2C with D-fenfluramine (diamonds, dashed line). There was a signif-
icant interaction of htr2c genotype with time on the difference in
glucose levels between saline and D-fenfluramine treatment (htr2c,
P  0.1; time, P  0.0001; htr2c  time, P  0.01).
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meostasis further establishes the serotonin system as a pos-
sible target for the treatment of diabetes mellitus itself.
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